EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Natural History of C3 Glomerulopathy and Immune Complex-Associated Membranoproliferative Glomerulonephritis in Children

Bradley P Dixon iD, Benjamin L Laskin, Amy J Goodwin Davies iD, Hanieh Razzaghi iD, Mitchell G Maltenfort, Sherin Meloni iD, Melissa E Thomas, Joseph T Flynn iD, Donna J Claes, Mark Mitsnefes, Brian R Stotter iD, Vikas R Dharnidharka iD und 8 weitere

Clinical Journal of the American Society of Nephrology · 2026

DOI: 10.2215/cjn.0000001118 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Journal of the American Society of Nephrology, 2026. Verfasst von Bradley P Dixon und 19 weiteren Autor:innen. Beteiligte Einrichtung: Renal Section, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado. Hauptthemen laut MEDLINE: Antigen-Antibody Complex, Complement C3, Glomerulonephritis, Membranoproliferative, Immune Complex Diseases. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Patient-Centered Outcomes Research Institute, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points C3 glomerulopathy and immune complex–associated membranoproliferative glomerulonephritis in children have similar degrees of proteinuria, hypoalbuminemia, hypertension, and hypocomplementemia at diagnosis. C3 glomerulopathy and immune complex–associated membranoproliferative glomerulonephritis in children progress similarly to a composite outcome of CKD, dialysis, or kidney transplantation. A low level of C3 at baseline is associated with achieving the composite outcome.

Background

C3 glomerulopathy (C3G) and immune complex–associated membranoproliferative glomerulonephritis (IC-MPGN) are rare complement-mediated kidney diseases with a high risk of progression to kidney failure. Little is known about the natural history of these diseases in children, limiting our understanding of risk factors for progressive kidney disease.

Methods

Using a computable phenotype algorithm, a pediatric cohort with C3G or IC-MPGN was identified at seven institutions in PEDSnet, a national network of pediatric health systems which aggregate electronic health record data and collaborate on pragmatic research studies. Discrete data elements were captured from electronic health records, and additional clinical and histopathologic data were extracted by standardized chart review by pediatric nephrologists. Biopsy diagnosis was classified as C3G or IC-MPGN by applying an algorithm on the basis of immunofluorescence and electron microscopy and supplemented with manual chart review. Kaplan–Meier survival curves were used to compare the risk of reaching a composite kidney outcome of 50% reduction in eGFR, initiation of maintenance dialysis, or kidney transplantation.

Results

Of 204 patients with membranoproliferative glomerulonephritis identified by the computable phenotype algorithm and chart review, 159 could be further classified as C3G or IC-MPGN on the basis of available biopsy data. There were no significant differences in baseline serum albumin, C3 level, urine protein/creatinine ratio, or eGFR between C3G and IC-MPGN. Patients with C3G and IC-MPGN had similar rates of progression to the composite kidney outcome, and a low serum C3 level at baseline was associated with this composite outcome.

Conclusion

Using large-scale, real-world multi-institutional data, we investigated the natural history of a large contemporary cohort of children with membranoproliferative glomerulonephritis. Because patients classified as having C3G compared with IC-MPGN had similar baseline clinical characteristics and rates of progressive disease despite untargeted treatment approaches, the availability of newer complement-targeted agents hold the promise of benefit to this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigen-Antibody ComplexComplement C3Glomerulonephritis, MembranoproliferativeImmune Complex DiseasesAdolescentChildChild, PreschoolFemaleHumansMaleAlgorithmsBiopsyDisease ProgressionKidneyKidney TransplantationPhenotypeRenal DialysisRisk FactorsTime Factors

Stichwörter der Autor:innen

Mpgn (membranoproliferative glomerulonephritis)cohort studiescomplementpediatric nephrology

Substanzen

Antigen-Antibody ComplexC3 protein, humanComplement C3

Autor:innen und Institutionen

  • Renal Section, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado.
  • Children's Hospital Colorado, Aurora, Colorado.
  • Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Perelman School of Medicine at the University of Pennsylvania.
  • Seattle Children's Hospital, Seattle, Washington.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

ORCID-Profile: Bradley P Dixon, Amy J Goodwin Davies, Hanieh Razzaghi, Sherin Meloni, Joseph T Flynn, Brian R Stotter, Vikas R Dharnidharka, Caroline A Gluck, Joshua Zaritsky, William E Smoyer, Susan L Furth

Förderung

  • NIDDK NIH HHS
  • Patient-Centered Outcomes Research Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Dixon, B. P., Laskin, B. L., Goodwin Davies, A. J., Razzaghi, H., Maltenfort, M. G., Meloni, S., Thomas, M. E., Flynn, J. T., Claes, D. J., Mitsnefes, M., Stotter, B. R., Dharnidharka, V. R., Gluck, C. A., Zaritsky, J., Somers, M. J., Kallash, M., Smoyer, W. E., Furth, S. L., Forrest, C. B., & Denburg, M. R. (2026). Natural History of C3 Glomerulopathy and Immune Complex-Associated Membranoproliferative Glomerulonephritis in Children. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.0000001118

Vancouver

Dixon BP, Laskin BL, Goodwin Davies AJ, Razzaghi H, Maltenfort MG, Meloni S, et al. Natural History of C3 Glomerulopathy and Immune Complex-Associated Membranoproliferative Glomerulonephritis in Children. Clinical Journal of the American Society of Nephrology. 2026. doi:10.2215/cjn.0000001118

BibTeX
@article{Dixon2026,
  author = {Dixon, Bradley P and Laskin, Benjamin L and Goodwin Davies, Amy J and Razzaghi, Hanieh and Maltenfort, Mitchell G and Meloni, Sherin and Thomas, Melissa E and Flynn, Joseph T and Claes, Donna J and Mitsnefes, Mark and Stotter, Brian R and Dharnidharka, Vikas R and Gluck, Caroline A and Zaritsky, Joshua and Somers, Michael J and Kallash, Mahmoud and Smoyer, William E and Furth, Susan L and Forrest, Christopher B and Denburg, Michelle R},
  title = {Natural History of C3 Glomerulopathy and Immune Complex-Associated Membranoproliferative Glomerulonephritis in Children},
  journal = {Clinical Journal of the American Society of Nephrology},
  year = {2026},
  doi = {10.2215/cjn.0000001118}
}
Kostenlos starten →